Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Olson

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Cancer Genetics|March 25, 2015
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemiaDaria V Babushok, Nieves Perdigones, Juan C Perin, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Uncovering the Genetic Etiology of Inherited Bone Marrow Failure Syndromes Using a Custom-Designed Next-Generation Sequencing PanelFumin Lin, Kajia Cao, Fengqi Chang, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2021
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disordersRebecca A Marsh, Kyle Hebert, Soyoung Kim, et al.
Haematologica|April 16, 2026
Immunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative studyTalya Wittmann Dayagi, Laura Willis, Staci D Arnold, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Nature Reviews. Clinical Oncology|January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Blood Advances|October 4, 2017
Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal ComplicationsDaria V Babushok, Jamie L Duke, Hongbo M Xie, et al.
The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β<sup>0</sup>/β<sup>0</sup> Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.
Haematologica|November 27, 2025
Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemiaRegina M Myers, Yimei Li, Hongyan Liu, et al.
Blood|January 12, 2026
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemiaJanet L Kwiatkowski, Alexis A Thompson, Jennifer Schneiderman, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Cancer Genetics|March 25, 2015
Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemiaDaria V Babushok, Nieves Perdigones, Juan C Perin, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Uncovering the Genetic Etiology of Inherited Bone Marrow Failure Syndromes Using a Custom-Designed Next-Generation Sequencing PanelFumin Lin, Kajia Cao, Fengqi Chang, et al.
The Journal of Allergy and Clinical Immunology|August 10, 2021
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disordersRebecca A Marsh, Kyle Hebert, Soyoung Kim, et al.
Haematologica|April 16, 2026
Immunosuppressive therapy for severe aplastic anemia in children under the age of 3 years yields a high response rate: a North American collaborative studyTalya Wittmann Dayagi, Laura Willis, Staci D Arnold, et al.
Haematologica|April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemiaMatthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Nature Reviews. Clinical Oncology|January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Blood Advances|October 4, 2017
Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal ComplicationsDaria V Babushok, Jamie L Duke, Hongbo M Xie, et al.
The New England Journal of Medicine|December 10, 2021
Betibeglogene Autotemcel Gene Therapy for Non-β<sup>0</sup>/β<sup>0</sup> Genotype β-ThalassemiaFranco Locatelli, Alexis A Thompson, Janet L Kwiatkowski, et al.
Haematologica|November 27, 2025
Hematopoietic cell transplantation after CD19-directed CAR T-cell therapy for remission consolidation or relapse treatment in pediatric acute lymphoblastic leukemiaRegina M Myers, Yimei Li, Hongyan Liu, et al.
Blood|January 12, 2026
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemiaJanet L Kwiatkowski, Alexis A Thompson, Jennifer Schneiderman, et al.
Pageof 10